Search Results 81-90 of 21341 for anti-TNF drugs
... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...
Biologic medicines, such as infliximab (Remicade), adalimumab (Humira) or vedolizumab (Entyvio). These can reduce swelling and irritation in the colon. Surgery.
The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems. Medicines to treat COVID- ...
"When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...
Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... etanercept for the treatment of patients with psoriatic arthritis (PsA).
The purpose of this study is to assess the long-term safety and effectiveness of repeat treatment with adalimumab in pediatric patients who have ulcerative ...
... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Drugs & Supplements A-Z · Health Books · Healthy ... A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with ...
FDA-approved medicines for treating symptoms · Goals for treating symptoms · Cholinesterase inhibitors · Memantine · Medicine for agitation · Anti-amyloid treatment.
18-80 years of age, inclusive · Moderately to severely active UC as determined by the Mayo Clinic Score assessment (MCS) · Naive to treatment with any anti-TNF ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.